A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Efficacy and safety of post-scleral injection of triamcinolone acetonide for macular edema in branch retinal vein occlusion: 3 month results from a prospective randomized, controlled and open label clinical trial
[post]
2020
unpublished
To assess the safety and efficacy of post-scleral injection of triamcinolone acetonide (TA) in macular region to treat macular edema secondary to branch retinal vein occlusion (BRVO), and compare it with intravitreal injection of TA and Ranibizumab. Methods: This is a prospective, double masked and single-center study. Thirty-six eyes, one from each participant who was diagnosed with
doi:10.21203/rs.2.24134/v1
fatcat:tff7bniwvzen7m4xrb742scglu